logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Caspofungin/ceftriaxone/hydroxychloroquineBrugada syndrome and off-label use: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2021年 / 1861卷 / 1期
关键词:
D O I:
10.1007/s40278-021-97889-6
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:89 / 89
相关论文
共 50 条
  • [21] RituximabHypogammaglobulinaemia and off-label use: case report
    Reactions Weekly, 2023, 1956 (1) : 453 - 453
  • [22] PosaconazoleHepatotoxicity and off-label use: case report
    Reactions Weekly, 2024, 2021 (1) : 447 - 447
  • [23] ClozapineSyncope and off-label use: case report
    Reactions Weekly, 2022, 1930 (1) : 198 - 198
  • [24] COVID-19-vaccine/Ceftriaxone/RemdesivirLack of efficacy and off-label use: case report
    Reactions Weekly, 2024, 2026 (1) : 101 - 101
  • [25] LinezolidLeukopenia and off-label use: case report
    Reactions Weekly, 2025, 2044 (1) : 180 - 180
  • [26] IbrutinibNeutropenia and off-label use: case report
    Reactions Weekly, 2020, 1787 (1) : 271 - 271
  • [27] AntineoplasticsPancytopenia and off-label use: case report
    Reactions Weekly, 2020, 1825 (1) : 39 - 39
  • [28] DexmedetomidineHypotension and off-label use: case report
    Reactions Weekly, 2019, 1749 (1) : 172 - 172
  • [29] AzithromycinCardiotoxicity and Off-label use: case report
    Reactions Weekly, 2023, 1953 (1) : 100 - 100
  • [30] RituximabCellulitis and off-label use: case report
    Reactions Weekly, 2022, 1911 (1) : 363 - 363
← 12345 →